World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000060549
Date of registration: 23/01/2015
Prospective Registration: No
Primary sponsor: Global Orthopaedic Technology Pty Ltd
Public title: Radiographic evaluation of the Paragon femoral stem over 2 years post hip replacement surgery
Scientific title: Prospective clinical trial assessing subsidence and rotation after Paragon hip stem arthroplasty in patients with a primary diagnosis of non-inflammatory degenerative joint disease
Date of first enrolment: 12/12/2014
Target sample size: 50
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615000060549.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Single group;Type of endpoint: Safety/efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Mr Lyndon Crossley   
Address:  Global Orthopaedic Technology Pty Ltd Unit 10, 7 Meridian Place Baulkham Hills, NSW 2153 Australia
Telephone: +61 2 8887 0115
Email: Lyndon@globalortho.com.au
Affiliation: 
Name: Mr Lyndon Crossley   
Address:  Global Orthopaedic Technology Pty Ltd Unit 10, 7 Meridian Place Baulkham Hills, NSW 2153 Australia
Telephone: +61 2 8887 0115
Email: lyndon@globalortho,com.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: The individual clinically qualifies for a primary total hip replacment using the Paragon cementless hip stem study prosthesis.
The individual has a primary diagnosis of non-inflammatory degenerative joint disease.
The individual has signed a study specifc informed consent.
The individual is physically and mentally willing and able to comply with pre-operative and post-operative assessments and procedures.


Exclusion criteria: The individual has an active infection within the affected hip joint.
The individual has had a previous total hip replacement or hip fusion to the affected hip joint.
The individual has a neuromuscular or neurosensory deficit which limits the ability to assess the performance of the prosthesis.


Age minimum: 21 Years
Age maximum: 85 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
non-inflammatory degenerative joint disease;
non-inflammatory degenerative joint disease
Musculoskeletal - Osteoarthritis
Surgery - Surgical techniques
Intervention(s)
Patients undergoing primary total hip replacement and suitable for the cementless Paragon hip stem will be selected. Radiographic visible tantalum beads are inserted around the hip prosthesis during surgery. The procedure adds approx 10 minutes to the standard total hip replacment surgery time.
Primary Outcome(s)
To determine the movement patterns of the Paragon femoral stem for the first 2 years post surgery using radiostereogrammetric analysis.[Post-operative at,
6 weeks
6 months
12 months
24 months]
Secondary Outcome(s)
Functional evaluation will be measured pre-operative to post-operative using the Oxford Hip Score. [Pre-operative
Post-operative at,
6 weeks
6 months
12 months
24 months]
Health related quality of life evaluation will be measured using the EQ-5D questionnaire.[Pre-operative
Post-operative at,
6 weeks
6 months
12 months
24 months]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Global Orthopaedic Technology Pty Ltd
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Nepean Blue Mountains Local Health District HREC
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history